81_FR_2874 81 FR 2863 - Request for Information on Development of a Performance Test Protocol for Closed System Transfer Devices That Incorporate Air-Cleaning Technology To Provide Worker Protection During Pharmacy Compounding and Administration of Hazardous Drugs

81 FR 2863 - Request for Information on Development of a Performance Test Protocol for Closed System Transfer Devices That Incorporate Air-Cleaning Technology To Provide Worker Protection During Pharmacy Compounding and Administration of Hazardous Drugs

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 81, Issue 11 (January 19, 2016)

Page Range2863-2864
FR Document2016-00827

The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) requests information for the development of a test protocol to evaluate the performance of closed system drug-transfer devices (CSTDs) that adopt air-cleaning technologies. CSTDs are generally available in two design types: (1) One that uses a physical barrier to block the unintended release of drug into the surrounding environment or the intake of environmental contaminants into the sterile drug pathway and (2) one that uses air cleaning or filtration technologies to prevent the unintended release of drug into the surrounding environment or the intake of environmental contaminants into the sterile drug pathway. A draft protocol titled, ``A Vapor Containment Performance Protocol for Closed System Transfer Devices Used During Pharmacy Compounding and Administration of Hazardous Drugs,'' was developed by NIOSH to evaluate how protective the physical barrier-type CSTD devices were as an indicator of how effective they would be at preventing hazardous drug escape from the closed system. This RFI seeks information from the public regarding the feasibility of developing a protocol applicable to CSTDs using air cleaning or filtration technologies and to request information from stakeholders on this topic.

Federal Register, Volume 81 Issue 11 (Tuesday, January 19, 2016)
[Federal Register Volume 81, Number 11 (Tuesday, January 19, 2016)]
[Notices]
[Pages 2863-2864]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-00827]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket Number CDC-2015-0075; NIOSH-288]


Request for Information on Development of a Performance Test 
Protocol for Closed System Transfer Devices That Incorporate Air-
Cleaning Technology To Provide Worker Protection During Pharmacy 
Compounding and Administration of Hazardous Drugs

AGENCY: National Institute for Occupational Safety and Health (NIOSH) 
of the Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Request for information and comment.

-----------------------------------------------------------------------

SUMMARY: The National Institute for Occupational Safety and Health 
(NIOSH) of the Centers for Disease Control and Prevention (CDC) 
requests information for the development of a test protocol to evaluate 
the performance of closed system drug-transfer devices (CSTDs) that 
adopt air-cleaning technologies. CSTDs are generally available in two 
design types: (1) One that uses a physical barrier to block the 
unintended release of drug into the surrounding environment or the 
intake of environmental contaminants into the sterile drug pathway and 
(2) one that uses air cleaning or filtration technologies to prevent 
the unintended release of drug into the surrounding environment or the 
intake of environmental contaminants into the sterile drug pathway. A 
draft protocol titled, ``A Vapor Containment Performance Protocol for 
Closed System Transfer Devices Used During Pharmacy Compounding and 
Administration of Hazardous Drugs,'' was developed by NIOSH to evaluate 
how protective the physical barrier-type CSTD devices were as an 
indicator of how effective they would be at preventing hazardous drug 
escape from the closed system.
    This RFI seeks information from the public regarding the 
feasibility of developing a protocol applicable to CSTDs using air 
cleaning or filtration technologies and to request information from 
stakeholders on this topic.

Table of Contents

     DATES:
     ADDRESSES:
     INSTRUCTIONS:
     FOR FURTHER INFORMATION:

[[Page 2864]]

     BACKGROUND:
     INFORMATION NEEDS:

DATES: Electronic or written comments should be received on or before 
March 8, 2016.

ADDRESSES: You may submit comments identified by CDC-2015-0075 and 
Docket Number NIOSH-288 by any of the following methods:
     Federal eRulemaking Portal: http://www.regulations.gov. 
Follow the instructions for submitting comments.
     Mail: National Institute for Occupational Safety and 
Health, NIOSH Docket Office, 1090 Tusculum Avenue, MS C-34, Cincinnati, 
OH 45226-1998.
    Instructions: All information received in response to this notice 
must include the agency name and docket number (CDC-2015-0075; NIOSH-
288). All relevant comments received will be posted without change to 
www.regulations.gov, including any personal information provided. For 
access to the docket to read background documents or comments received, 
go to www.regulations.gov. All information received in response to this 
notice will also be available for public examination and copying at the 
NIOSH Docket Office, 1150 Tusculum Avenue, Room 155, Cincinnati, OH 
45226.

FOR FURTHER INFORMATION CONTACT: Gayle DeBord, NIOSH, Division of 
Applied Research and Technologies, Robert A. Taft Laboratories, 1090 
Tusculum Avenue, MS-R2, Cincinnati, Ohio 45226, Phone: (513) 841-4256 
[not a toll-free number], Email: [email protected].
    Background: The purpose of the RFI is to seek information relative 
to the development of a performance evaluation protocol for CSTDs using 
air cleaning or filtration technologies. The draft protocol released 
for public comment on September 8, 2015 [80 FR 53802] is applicable to 
barrier-type CSTDs only. This RFI expands the scope of the previous RFI 
to seek information to support development of a companion protocol that 
would apply to CSTDs using air cleaning or filtration technologies, 
thus covering the remainder of the currently known CSTD marketplace.
    Information Needs: Additional data and information are needed to 
assist NIOSH to develop or adapt a test protocol for evaluating the 
efficiency of air cleaning or filtration technologies CSTDs. In 
particular, NIOSH requests submission of existing test protocols 
developed for efficacy testing of air cleaning or filtration 
technologies CSTDs.
    The National Institute for Occupational Safety and Health seeks 
public comments in response to the following questions. Please feel 
free to comment on any or all of the questions below:
    1. Are there any other types of CSTDs available that would not fit 
into the two categories described, i.e., (1) barrier systems, and (2) 
air-cleaning or filtration technologies?
    2. Is there an existing test protocol for evaluation of the 
protective efficacy of air-cleaning or filtration technologies CSTDs? 
Can this test protocol, and/or the details of the underlying procedures 
and test data be shared with NIOSH?
    Please apply the following questions to a protocol you have 
developed, one you are aware of, or one you believe to be feasible to 
develop:
    3. Are there any special restrictions, limiting assumptions or 
requirements for expertise required to conduct the protocol?
    4. What are the performance criteria used with the protocol tests 
to determine acceptability and judge conformity?
    4. Does the protocol apply to compounding operations, 
administration activities or both?
    5. Does this protocol use a surrogate or does it require testing 
against the actual hazardous drugs?
    6. If a surrogate is used,
    a. Does the surrogate represent all hazardous drugs or a subset?
    b. Which criteria are used in selection of the surrogate?
    c. Describe how the selection criteria address the degree to which 
the surrogate or surrogates are representative of the class of 
hazardous drugs to which they apply.
    d. Does the surrogate introduce any potential worker exposure 
hazards?
    7. List the hazardous drugs for which this protocol has been used.
    a. How were these hazardous drugs selected?
    b. Were there any hazardous drugs for which the test protocol was 
not or would not be successful or compatible?
    c. During protocol application, in what state were the hazardous 
drugs, e.g., full strength as delivered, full strength reconstituted, 
patient dose with diluent, or drug cocktail?
    8. What procedure(s) can be used to verify that the protocol is 
applicable for new hazardous drugs as they are identified and brought 
to market?
    9. Can the test protocol be used effectively for different 
formulations of the same active pharmaceutical ingredient?
    10. If applicable, are you willing to share details of your test 
protocol with NIOSH? Would you be willing for the protocol details to 
be shared publicly or would you require the test protocol details to be 
protected as proprietary information?
    11. If applicable, are you willing to share test results from the 
application of your air cleaning or filtration technologies CSTD test 
protocol with NIOSH?
    12. Are you interested in being a collaborative partner with NIOSH 
on the development of an air cleaning or filtration technologies CSTD 
test protocol?
    Responses to this notice are not offers and cannot be accepted by 
the Government to form a binding contract or to issue a grant. 
Information obtained as a result of this RFI may be used by the 
government for program planning on a non-attribution basis. Please do 
not include any information that might be considered proprietary, 
confidential, or personally identifying (such as home address or social 
security number).

    Dated: January 12, 2016.
John Howard,
Director, National Institute for Occupational Safety and Health, 
Centers for Disease Control and Prevention.
[FR Doc. 2016-00827 Filed 1-15-16; 8:45 am]
 BILLING CODE 4163-19-P



                                                                                  Federal Register / Vol. 81, No. 11 / Tuesday, January 19, 2016 / Notices                                           2863

                                                    ACTION:   Meeting notice.                               291, div. B, S3091, Dec. 19, 2014)), as                DEPARTMENT OF HEALTH AND
                                                                                                            a commission to ensure a suitable                      HUMAN SERVICES
                                                    SUMMARY:    Notice of this meeting is being             observance of the centennial of World
                                                    provided according to the requirements                  War I, to provide for the designation of               Centers for Disease Control and
                                                    of the Federal Advisory Committee Act,                                                                         Prevention
                                                                                                            memorials to the service of members of
                                                    5 U.S.C. App. 10(a)(2). This notice
                                                                                                            the United States Armed Forces in                      [Docket Number CDC–2015–0075; NIOSH–
                                                    provides the schedule and agenda for
                                                                                                            World War I, and for other purposes.                   288]
                                                    the January 25, 2016 meeting of the
                                                    World War One Centennial Commission                       Under this authority, the Committee
                                                                                                                                                                   Request for Information on
                                                    (the Commission). The meeting is open                   will plan, develop, and execute                        Development of a Performance Test
                                                    to the public.                                          programs, projects, and activities to                  Protocol for Closed System Transfer
                                                    DATES: The meeting will be held on                      commemorate the centennial of World                    Devices That Incorporate Air-Cleaning
                                                    Monday, January 25, 2016 starting at 10                 War I, encourage private organizations                 Technology To Provide Worker
                                                    a.m. Eastern Standard Time (EST), and                   and State and local governments to                     Protection During Pharmacy
                                                    ending no later than 12:30 p.m., (EST).                 organize and participate in activities                 Compounding and Administration of
                                                    ADDRESSES: The meeting will be held at                  commemorating the centennial of World                  Hazardous Drugs
                                                    the office of the Jones Day Law firm at                 War I, facilitate and coordinate activities
                                                    51 Louisiana Ave. NW., Washington, DC                   throughout the United States relating to               AGENCY:  National Institute for
                                                    20001–2105. This location is                            the centennial of World War I, serve as                Occupational Safety and Health
                                                    handicapped accessible. The meeting                     a clearinghouse for the collection and                 (NIOSH) of the Centers for Disease
                                                    will be open to the public and will also                dissemination of information about                     Control and Prevention (CDC),
                                                    be available telephonically. Persons                                                                           Department of Health and Human
                                                                                                            events and plans for the centennial of
                                                    attending in person are requested to                                                                           Services (HHS).
                                                                                                            World War I, and develop
                                                    refrain from using perfume, cologne,                                                                           ACTION: Request for information and
                                                                                                            recommendations for Congress and the
                                                    and other fragrances (see http://                       President for commemorating the                        comment.
                                                    www.accessboard.gov/about/policies/                     centennial of World War I. The                         SUMMARY:    The National Institute for
                                                    fragrance.htm for more information).                    Commission does not have an                            Occupational Safety and Health
                                                       Persons wishing to listen to the                     appropriation and operated solely on                   (NIOSH) of the Centers for Disease
                                                    proceedings may dial 712–432–1001                       donated funds.                                         Control and Prevention (CDC) requests
                                                    and enter access code 474845614. Note                                                                          information for the development of a
                                                    this is not a toll-free number. Written                 Agenda: Monday, January 25, 2016
                                                                                                                                                                   test protocol to evaluate the
                                                    Comments may be submitted to the                                                                               performance of closed system drug-
                                                                                                            Old Business
                                                    Commission and will be made part of                                                                            transfer devices (CSTDs) that adopt air-
                                                    the permanent record of the                              • Approval of minutes of previous                     cleaning technologies. CSTDs are
                                                    Commission. Comments must be                            meetings                                               generally available in two design types:
                                                    received by 5:00 p.m., (EST), January 21,
                                                    2016, and may be provided by email to:                   • Public Comment Period                               (1) One that uses a physical barrier to
                                                                                                                                                                   block the unintended release of drug
                                                    daniel.dayton@                                          New Business                                           into the surrounding environment or the
                                                    worldwar1centennial.org. Contact                                                                               intake of environmental contaminants
                                                    Daniel S. Dayton at daniel.dayton@                        • Commission Operating Status
                                                                                                                                                                   into the sterile drug pathway and (2)
                                                    worldwar1centennial.org to register to                    • Requests for Support                               one that uses air cleaning or filtration
                                                    comment in person during the meeting’s
                                                                                                              • WWI Memorial at Pershing Park—                     technologies to prevent the unintended
                                                    30 minute public comment period.                                                                               release of drug into the surrounding
                                                       Registered speakers/organizations will               Discussion and Vote
                                                                                                                                                                   environment or the intake of
                                                    be allowed 5 minutes and will need to                     • International Report
                                                                                                                                                                   environmental contaminants into the
                                                    provide written copies of their                           • Chairman’s Report                                  sterile drug pathway. A draft protocol
                                                    presentations. Requests to comment at
                                                    the meeting must be received by 5 p.m.                    • Next Meeting                                       titled, ‘‘A Vapor Containment
                                                                                                              Other business as may properly come                  Performance Protocol for Closed System
                                                    Eastern time, January 21, 2016. Written
                                                                                                                                                                   Transfer Devices Used During Pharmacy
                                                    presentations may be provided to Mr.                    before the Commission Adjourns.
                                                                                                                                                                   Compounding and Administration of
                                                    Dayton at daniel.dayton@                                  Dated: January 13, 2016.                             Hazardous Drugs,’’ was developed by
                                                    worldwar1centennial.org until
                                                                                                            Daniel S. Dayton,                                      NIOSH to evaluate how protective the
                                                    Thursday, January 21, 2016. Please
                                                                                                            Designated Federal Official, World War I               physical barrier-type CSTD devices
                                                    contact Mr. Dayton at the email address
                                                                                                            Centennial Commission.                                 were as an indicator of how effective
                                                    above to obtain meeting materials.
                                                                                                            [FR Doc. 2016–00911 Filed 1–15–16; 8:45 am]            they would be at preventing hazardous
                                                    FOR FURTHER INFORMATION CONTACT:                                                                               drug escape from the closed system.
                                                    Daniel S. Dayton, Designated Federal                    BILLING CODE 6820–95–P
                                                                                                                                                                      This RFI seeks information from the
                                                    Officer, World War 1 Centennial                                                                                public regarding the feasibility of
                                                    Commission, 701 Pennsylvania Avenue                                                                            developing a protocol applicable to
                                                    NW., 123, Washington, DC 20004–2608,
asabaliauskas on DSK5VPTVN1PROD with NOTICES




                                                                                                                                                                   CSTDs using air cleaning or filtration
                                                    at 202–380–0725 (note: this is not a toll-                                                                     technologies and to request information
                                                    free number).                                                                                                  from stakeholders on this topic.
                                                    SUPPLEMENTARY INFORMATION:
                                                                                                                                                                   Table of Contents
                                                    Background
                                                                                                                                                                     •     DATES:
                                                      The World War One Centennial                                                                                   •     ADDRESSES:
                                                    Commission was established by Public                                                                             •     INSTRUCTIONS:
                                                    Law 112–272 (as amended (Pub. L. 113–                                                                            •     FOR FURTHER INFORMATION:


                                               VerDate Sep<11>2014   17:50 Jan 15, 2016   Jkt 238001   PO 00000   Frm 00027   Fmt 4703   Sfmt 4703   E:\FR\FM\19JAN1.SGM    19JAN1


                                                    2864                          Federal Register / Vol. 81, No. 11 / Tuesday, January 19, 2016 / Notices

                                                       • BACKGROUND:                                        public comments in response to the                     would you require the test protocol
                                                       • INFORMATION NEEDS:                                 following questions. Please feel free to               details to be protected as proprietary
                                                    DATES: Electronic or written comments                   comment on any or all of the questions                 information?
                                                    should be received on or before March                   below:                                                    11. If applicable, are you willing to
                                                    8, 2016.                                                   1. Are there any other types of CSTDs               share test results from the application of
                                                    ADDRESSES: You may submit comments                      available that would not fit into the two              your air cleaning or filtration
                                                    identified by CDC–2015–0075 and                         categories described, i.e., (1) barrier                technologies CSTD test protocol with
                                                    Docket Number NIOSH–288 by any of                       systems, and (2) air-cleaning or filtration            NIOSH?
                                                                                                            technologies?                                             12. Are you interested in being a
                                                    the following methods:
                                                                                                               2. Is there an existing test protocol for           collaborative partner with NIOSH on the
                                                       • Federal eRulemaking Portal: http://
                                                                                                            evaluation of the protective efficacy of               development of an air cleaning or
                                                    www.regulations.gov. Follow the
                                                                                                            air-cleaning or filtration technologies                filtration technologies CSTD test
                                                    instructions for submitting comments.
                                                                                                            CSTDs? Can this test protocol, and/or                  protocol?
                                                       • Mail: National Institute for
                                                                                                            the details of the underlying procedures                  Responses to this notice are not offers
                                                    Occupational Safety and Health, NIOSH                                                                          and cannot be accepted by the
                                                    Docket Office, 1090 Tusculum Avenue,                    and test data be shared with NIOSH?
                                                                                                               Please apply the following questions                Government to form a binding contract
                                                    MS C–34, Cincinnati, OH 45226–1998.                                                                            or to issue a grant. Information obtained
                                                       Instructions: All information received               to a protocol you have developed, one
                                                                                                            you are aware of, or one you believe to                as a result of this RFI may be used by
                                                    in response to this notice must include                                                                        the government for program planning on
                                                    the agency name and docket number                       be feasible to develop:
                                                                                                               3. Are there any special restrictions,              a non-attribution basis. Please do not
                                                    (CDC–2015–0075; NIOSH–288). All                                                                                include any information that might be
                                                    relevant comments received will be                      limiting assumptions or requirements
                                                                                                            for expertise required to conduct the                  considered proprietary, confidential, or
                                                    posted without change to                                                                                       personally identifying (such as home
                                                    www.regulations.gov, including any                      protocol?
                                                                                                               4. What are the performance criteria                address or social security number).
                                                    personal information provided. For
                                                    access to the docket to read background                 used with the protocol tests to                          Dated: January 12, 2016.
                                                    documents or comments received, go to                   determine acceptability and judge                      John Howard,
                                                    www.regulations.gov. All information                    conformity?                                            Director, National Institute for Occupational
                                                    received in response to this notice will                   4. Does the protocol apply to                       Safety and Health, Centers for Disease Control
                                                    also be available for public examination                compounding operations,                                and Prevention.
                                                    and copying at the NIOSH Docket                         administration activities or both?                     [FR Doc. 2016–00827 Filed 1–15–16; 8:45 am]
                                                                                                               5. Does this protocol use a surrogate
                                                    Office, 1150 Tusculum Avenue, Room                                                                             BILLING CODE 4163–19–P
                                                                                                            or does it require testing against the
                                                    155, Cincinnati, OH 45226.
                                                                                                            actual hazardous drugs?
                                                    FOR FURTHER INFORMATION CONTACT:                           6. If a surrogate is used,                          DEPARTMENT OF HEALTH AND
                                                    Gayle DeBord, NIOSH, Division of                           a. Does the surrogate represent all                 HUMAN SERVICES
                                                    Applied Research and Technologies,                      hazardous drugs or a subset?
                                                    Robert A. Taft Laboratories, 1090                          b. Which criteria are used in selection             Centers for Disease Control and
                                                    Tusculum Avenue, MS–R2, Cincinnati,                     of the surrogate?                                      Prevention
                                                    Ohio 45226, Phone: (513) 841–4256 [not                     c. Describe how the selection criteria
                                                    a toll-free number], Email:                                                                                    [30Day–16–15BBU]
                                                                                                            address the degree to which the
                                                    hazardousdrugs@cdc.gov.                                 surrogate or surrogates are                            Agency Forms Undergoing Paperwork
                                                       Background: The purpose of the RFI                   representative of the class of hazardous               Reduction Act Review
                                                    is to seek information relative to the                  drugs to which they apply.
                                                    development of a performance                               d. Does the surrogate introduce any                    The Centers for Disease Control and
                                                    evaluation protocol for CSTDs using air                 potential worker exposure hazards?                     Prevention (CDC) has submitted the
                                                    cleaning or filtration technologies. The                   7. List the hazardous drugs for which               following information collection request
                                                    draft protocol released for public                      this protocol has been used.                           to the Office of Management and Budget
                                                    comment on September 8, 2015 [80 FR                        a. How were these hazardous drugs                   (OMB) for review and approval in
                                                    53802] is applicable to barrier-type                    selected?                                              accordance with the Paperwork
                                                    CSTDs only. This RFI expands the scope                     b. Were there any hazardous drugs for               Reduction Act of 1995. The notice for
                                                    of the previous RFI to seek information                 which the test protocol was not or                     the proposed information collection is
                                                    to support development of a companion                   would not be successful or compatible?                 published to obtain comments from the
                                                    protocol that would apply to CSTDs                         c. During protocol application, in                  public and affected agencies.
                                                    using air cleaning or filtration                        what state were the hazardous drugs,                      Written comments and suggestions
                                                    technologies, thus covering the                         e.g., full strength as delivered, full                 from the public and affected agencies
                                                    remainder of the currently known CSTD                   strength reconstituted, patient dose with              concerning the proposed collection of
                                                    marketplace.                                            diluent, or drug cocktail?                             information are encouraged. Your
                                                       Information Needs: Additional data                      8. What procedure(s) can be used to                 comments should address any of the
                                                    and information are needed to assist                    verify that the protocol is applicable for             following: (a) Evaluate whether the
                                                    NIOSH to develop or adapt a test                        new hazardous drugs as they are                        proposed collection of information is
                                                    protocol for evaluating the efficiency of               identified and brought to market?                      necessary for the proper performance of
asabaliauskas on DSK5VPTVN1PROD with NOTICES




                                                    air cleaning or filtration technologies                    9. Can the test protocol be used                    the functions of the agency, including
                                                    CSTDs. In particular, NIOSH requests                    effectively for different formulations of              whether the information will have
                                                    submission of existing test protocols                   the same active pharmaceutical                         practical utility; (b) Evaluate the
                                                    developed for efficacy testing of air                   ingredient?                                            accuracy of the agencies estimate of the
                                                    cleaning or filtration technologies                        10. If applicable, are you willing to               burden of the proposed collection of
                                                    CSTDs.                                                  share details of your test protocol with               information, including the validity of
                                                       The National Institute for                           NIOSH? Would you be willing for the                    the methodology and assumptions used;
                                                    Occupational Safety and Health seeks                    protocol details to be shared publicly or              (c) Enhance the quality, utility, and


                                               VerDate Sep<11>2014   17:50 Jan 15, 2016   Jkt 238001   PO 00000   Frm 00028   Fmt 4703   Sfmt 4703   E:\FR\FM\19JAN1.SGM   19JAN1



Document Created: 2016-01-16 01:10:39
Document Modified: 2016-01-16 01:10:39
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionRequest for information and comment.
DatesElectronic or written comments should be received on or before March 8, 2016.
ContactGayle DeBord, NIOSH, Division of Applied Research and Technologies, Robert A. Taft Laboratories, 1090 Tusculum Avenue, MS-R2, Cincinnati, Ohio 45226, Phone: (513) 841-4256 [not a toll-free number], Email: [email protected]
FR Citation81 FR 2863 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR